In a groundbreaking study, Japanese scientists have uncovered the genetic basis of autism through a study on KMT2C haploinsufficiency in mice. This discovery has revealed the therapeutic potential of targeting the KMT2C gene, which is associated with autism, offering new avenues for the development of targeted treatments for the disorder.
The relationship between the gut microbiome and autism spectrum disorder (ASD) has eluded the most brilliant minds for over two decades. However, new technology offers a ray of hope. In a groundbreaking study, scientists have found a “definitive association” between temporal changes in gut microbiome composition and ASD. This association has been confirmed through the use of a novel algorithm that delved into decades of research, revealing an intricate relationship between the gut microbiome and ASD.
The gut microbiome is the community of microorganisms – ‘good’ and ‘bad’ bacteria – residing in our digestive tract. The healthy balance of these bacteria plays a vital role in digestion, metabolism, immune function, and overall health.